Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-severe Pain Following Abdominal Surgery
Phase 3
Completed
- Conditions
- Participants With Acute Moderate to Severe Pain Following Abdominal Surgery
- Interventions
- First Posted Date
- 2025-04-01
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Yangtze River Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 224
- Registration Number
- NCT06904248
- Locations
- 🇨🇳
Cangzhou People's Hospital, Cangzhou, China
🇨🇳The Third Xiangya Hospital Of Central South University, Changsha, China
🇨🇳Heping Hospital Affiliated To Changzhi Medical College, Changzhi, China
Safety, Tolerability and Pharmacokinetics of Meloxicam Nanocrystal Injection in Healthy Subjects
Phase 1
Completed
- Conditions
- Pain
- Interventions
- Drug: Meloxicam Nanocrystal Injection(Yangtze River Pharmaceutical Group Co., Ltd.)Drug: Meloxicam Nanocrystal Injection (ANJESO®)
- First Posted Date
- 2025-03-30
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Yangtze River Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT06902090
- Locations
- 🇨🇳
Sichuan Provincial People's Hospital, Chengdu, Sichuan, China
Effect of Dezocine Combined With Sufentanil on the Quality of Postoperative Recovery and Analgesic Effect in Patients Undergoing Thoracic Surgery
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- Yangtze River Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 210
- Registration Number
- NCT06439368
- Locations
- 🇨🇳
Nanfang Hospital of Southern Medical University, Guangzhou, Guangzhou, China
A Study of the Interaction of Tunodafil Hydrochloride Tablets and Alcohol
Phase 1
Completed
- Conditions
- Erectile Dysfunction
- Interventions
- Drug: Tunodafil Hydrochloride TabletsDrug: PlaceboOther: Alcohol
- First Posted Date
- 2023-08-04
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- Yangtze River Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 22
- Registration Number
- NCT05976503
- Locations
- 🇨🇳
Peking University People's Hospital, Peking, China
© Copyright 2025. All Rights Reserved by MedPath